Cost Plus Drugs expands portfolio with Starjemza
Cost Plus Drugs Adds Starjemza to Portfolio Mark Cuban Cost Plus Drug Company announced the inclusion of Starjemza, a biosimilar medication, in its expanding lineup of affordable prescript…
Cost Plus Drugs Adds Starjemza to Portfolio Mark Cuban Cost Plus Drug Company announced the inclusion of Starjemza, a biosimilar medication, in its expanding lineup of affordable prescript…
Ola Electric’s Path Toward Profitability Ola Electric is entering a critical phase as it tries to turn strong gross margin discipline and…
EU Agrees on New Climate Targets Ahead of COP30 European Union member states have finalized a new climate agreement after prolonged negoti…
Flight Refunds and Flexibility amid New FAA Air Travel Restrictions The FAA has introduced new air travel restrictions expected to intensi…
A Modern Classic Gangster Movie Airing on TV Tonight Tonight's TV movie pick for 8 November is Gangs of New York, the period gan…
Dubai Launches ‘1 Billion Acts of Kindness’ Campaign The 1 Billion Followers Summit has partnered with global content creator MrBeast (Ji…
Capri Holdings Exceeds Quarterly Revenue Expectations Capri Holdings reported stronger-than-expected revenue for the second quarter, drive…